Yi Hu

USPTO Granted Patents = 20 (Patent Applications = 1)

CIPO Patents = 2

EPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 3.3

ph-index = 3

Forward Citations = 38(Granted Patents)

Location History:

The Woodlands, TX (US) (2003 - 2004)
Woodlands, TX (US) (2005)
Spring, TX (US) (2003 - 2007)
San Diego, CA (US) (2011)

Company Filing History:

16 out of 102

Lexicon Genetics Corporation

patents

2 out of 86

Lexicon Pharmaceuticals, Inc.

patents

1 out of 1

Lexion Genetics Incorporated

patent

4. 1 out of 185

Kyorin Pharmaceutical Co., Ltd.

patents

Years Active: 2003-2011

Loading Chart...

20 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7879846 - Serine hydrolase inhibitors (2011-02-01),

2. 7312079 - Variants of FAM3C (2007-12-25),

3. 7229790 - Human GABA transporter protein and polynucleotides encoding the same (2007-06-12),

4. 7105325 - Human hydroxylases and polynucleotides encoding the same (2006-09-12),

5. 6994995 - Human synaptotagmin and polynucleotides encoding the same (2006-02-07),

6. 6908758 - Human kinase proteins and polynucleotides encoding the same (2005-06-21),

7. 6900045 - Human kinase proteins and polynucleotides encoding the same (2005-05-31),

8. 6875587 - Human protease inhibitor and polynucleotides encoding the same (2005-04-05),

9. 6867025 - Human hydroxylases and polynucleotides encoding the same (2005-03-15),

10. 6841377 - Human kinase and polynucleotides encoding the same (2005-01-11),

11. 6803221 - Human kinase and polynucleotides encoding the same (2004-10-12),

12. 6773906 - Human kinase and polynucleotides encoding the same (2004-08-10),

13. 6767736 - Human ion channel protein and polynucleotides encoding the same (2004-07-27),

14. 6617147 - Human kinase proteins and polynucleotides encoding the same (2003-09-09),

15. 6593126 - Human kinase and polynucleotides encoding the same (2003-07-15),

Title: The Innovations of Yi Hu: Pioneering Advances in Therapeutics

Introduction: Yi Hu, based in Spring, Texas, is an accomplished inventor known for his contributions to the fields of therapeutics and diagnostics. With a remarkable 19 granted patents, he has focused on advancements that have vast potential in pharmacogenomics and novel therapies for various medical conditions.

Latest Patents: Among Yi Hu's most recent patents are groundbreaking discoveries involving variants of the FAM3C gene. His work includes the disclosure of polynucleotide and polypeptide sequences that encode novel variant FAM3C proteins, which hold promise for therapeutic, diagnostic, and pharmacogenomic applications. Additionally, he has developed novel human polynucleotide and polypeptide sequences related to the human GABA transporter protein, further expanding the potential for innovative treatments and diagnostics.

Career Highlights: Throughout his career, Yi Hu has made significant contributions while working for celebrated organizations like Lexicon Genetics Corporation and Lexicon Pharmaceuticals, Inc. His research and innovations have played a crucial role in advancing medicine, particularly in the understanding and treatment of complex health issues.

Collaborations: In his journey, Yi Hu has collaborated with esteemed professionals, including Boris Nepomnichy and D Wade Walke. These partnerships have not only enriched his research but have fostered a collaborative environment that encourages shared knowledge and innovative thinking.

Conclusion: Yi Hu stands out as a leading inventor whose work continues to influence the scientific community. With numerous patents and innovative projects, he exemplifies the spirit of innovation that can lead to significant improvements in health care and therapeutic practices. His ongoing contributions are likely to pave the way for future breakthroughs in the medical field.

This text is generated by artificial intelligence and may not be accurate.